Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance

Apr 13, 2016 · 2m 19s
Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance
Description
Dr. Ross Camidge, University of Colorado, addresses the question of whether to use a second generation ALK inhibitor as first line therapy or only after acquired resistance to crizotinib.
Information
Author cancerGRACE
Organization cancerGRACE
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search